RosuvastatinCalcium CAS:147098-20-2

Rosuvastatin Calcium is primarily used for managing dyslipidemia, including hypercholesterolemia and mixed dyslipidemia. It is indicated for patients with elevated LDL cholesterol levels or combined hyperlipidemia, especially those at high risk of cardiovascular events. The primary therapeutic goal of Rosuvastatin Calcium is to lower LDL cholesterol levels and improve lipid profiles, thereby reducing the risk of atherosclerosis and cardiovascular morbidity and mortality. Additionally, Rosuvastatin Calcium may be prescribed for individuals with familial hypercholesterolemia, a genetic disorder characterized by high cholesterol levels from birth. It helps lower LDL cholesterol levels in these patients and reduces the progression of atherosclerosis, ultimately decreasing the incidence of cardiovascular complications such as coronary artery disease and myocardial infarction. Moreover, Rosuvastatin Calcium has been studied for its potential benefits beyond lipid-lowering effects. Emerging research suggests that it may possess pleiotropic effects, including anti-inflammatory, antioxidant, and endothelial function-improving properties. These additional mechanisms of action could contribute to its cardioprotective effects and may have implications for the prevention and treatment of other cardiovascular conditions, such as heart failure and atrial fibrillation. Furthermore, Rosuvastatin Calcium has been investigated for its potential role in reducing the risk of cardiovascular events in various patient populations, including those with diabetes mellitus, chronic kidney disease, or previous cardiovascular events. Clinical trials have demonstrated its efficacy in lowering LDL cholesterol and reducing adverse cardiovascular outcomes, leading to its widespread use as a cornerstone therapy for cardiovascular risk reduction. Overall, Rosuvastatin Calcium is a widely prescribed medication for managing dyslipidemia and reducing the risk of cardiovascular events. Its efficacy, safety profile, and additional pleiotropic effects make it a valuable therapeutic option for improving cardiovascular health and reducing the burden of cardiovascular diseases globally.